Evidence map›Paper›PMID 40297760›Full record

ArticleMolecular therapy. Methods & clinical development2025

WRAP-based nanoparticles for siRNA delivery in zebrafish embryos by simple bath immersion.

Karidia Konate, Clémentine A Teko-Agbo, Irène Pezzati, Thania Hammoum, Sébastien Deshayes, Simon Descamps, Eric Vivès, Sandrine Faure, Pascal de Santa Barbara, Prisca Boisguérin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Formulation of Peptide-Based Nanoparticles Using a Microfluidic Device.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karidia KonatePHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Clémentine A Teko-AgboPHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Irène PezzatiPHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Thania HammoumPHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Sébastien DeshayesPHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Simon DescampsCell Biology Research of Montpellier (CRBM), University of Montpellier, UMR5237, Montpellier, France.
Eric VivèsPHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Sandrine FaurePHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Pascal de Santa BarbaraPHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.
Prisca BoisguérinPHYMEDEXP, University of Montpellier, INSERM U1046, CNRS UMR 9214, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of RNA interference (RNAi) is becoming more widespread in several areas of biomedical research. However, the success of RNAi depends on the effective delivery of siRNA

Indexed as

cell-penetrating peptideGFP silencingimmersionpeptide-based nanoparticlessiRNAzebrafish embryo

Identifiers

PMID40297760
PMCPMC12036052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.